The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

COVID-19 vaccines given to children last fall helped keep many out of emergency rooms and urgent care, new data shows.

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

The FDA has approved an oral pellet formulation of Orladeyo® to prevent attacks of hereditary angioedema in pediatric patients.